Background illustration for clinical trials search

Paid Clinical Trials Ann Arbor

Discover 1,760 paid clinical trials in Ann Arbor, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

for
Non-small Cell Lung Cancer (NSCLC)
Location: Detroit MI, Fort Wayne IN, Cleveland OH,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07361497

Phase 3, Recruiting

Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)

for
Von Hippel-Lindau Disease, Malignant Neoplasms
Location: Detroit MI, Pittsburgh PA, Nashville TN,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07405164

Phase 3, Recruiting

Horizon Two: HR NDMM (MMRC-100)

for
High Risk Newly Diagnosed Multiple Myeloma
Location: Detroit MI, Chicago IL, St Louis MO, Nashville TN,
Sponsor: Multiple Myeloma Research Consortium

Sex: All

Age: 18+

Code: NCT07053436

Phase 2, Recruiting

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

for
Ras-mutated Metastatic Colorectal Cancer, mCRC,
Location: Detroit MI, Canton OH, Colombus OH, Chicago IL,
Sponsor: Oncolytics Biotech

Sex: All

Age: 18+

Code: NCT07446322

Phase 2, Recruiting

MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer

for
Small Cell Lung Cancer, SCLC,
Location: Detroit MI, Indianapolis IN, Iowa City IA,
Sponsor: Hirva Mamdani

Sex: All

Age: 18+

Code: NCT05903092

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Detroit MI, Canton OH, Dayton OH, Chicago IL,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07518186

Phase 3, Recruiting

A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

for
Chronic Graft-versus-host-disease
Location: Detroit MI, Columbus OH, Chicago IL, Pittsburgh PA,
Sponsor: Syndax Pharmaceuticals

Sex: All

Age: 2+

Code: NCT04710576

Phase 2, Recruiting

A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer

for
Non Small Cell Lung Cancer
Location: Detroit MI, Cleveland OH, Pittsburgh PA, Fairfax VA,
Sponsor: Wayshine Biopharm, Inc.

Sex: All

Age: 18+

Code: NCT06868485

Phase 2, Recruiting

BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

for
HR+/HER2- Breast Cancer
Location: Detroit MI, Fort Wayne IN, Canton OH, Dayton OH,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07492641

Phase 3, Recruiting

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

for
Melanoma (Skin Cancer),
Location: Detroit MI, Cincinnati OH, Madison WI, Rochester NY,
Sponsor: Aminex Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07287917

Phase 1, Phase 2, Recruiting

A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors

for
Advanced or Metastatic Solid Tumors
Location: Detroit MI, Grand Rapids MI, Cleveland OH, Fairfax VA,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT07205718

Phase 1, Phase 2, Recruiting

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

for
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms,
Location: Detroit MI, Fort Wayne IN, Chicago IL, Indianapolis IN,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07218380

Phase 3, Recruiting

A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer

for
HER2-negative Breast Cancer, Hormone Receptor Positive Tumor,
Location: Detroit MI, Clarkston MI, Mount Clemens MI, Flint MI,
Sponsor: Barbara Ann Karmanos Cancer Institute

Sex: All

Age: 22+

Code: NCT07227831

Recruiting

Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)

for
Head and Neck Squamous Cell Carcinoma (HNSCC),
Location: Detroit MI, Chicago IL, Pittsburgh PA, Louisville KY,
Sponsor: Inhibrx Biosciences, Inc

Sex: All

Age: 18+

Code: NCT06295731

Phase 2, Phase 3, Recruiting

A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors

for
Neoplasms, Neoplasm Metastasis, Non-Small-Cell Lung Cancer
Location: Detroit MI, Canton OH, Boston MA
Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd.

Sex: All

Age: 18+

Code: NCT03797391

Phase 1, Phase 2, Recruiting

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

for
Solid Tumor, Adult, Refractory Cancer,
Location: Detroit MI, Indianapolis IN, Fairfax VA, New York NY,
Sponsor: GV20 Therapeutics

Sex: All

Age: 18+

Code: NCT05669430

Phase 1, Phase 2, Recruiting

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

for
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer,
Location: Detroit MI, Grand Rapids MI, Hilliard OH, Columbus OH,
Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

Sex: Female

Age: 18+

Code: NCT05128825

Phase 2, Recruiting

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

for
Prostate Cancer
Location: Detroit MI, Cleveland OH, Chicago IL, Hamilton,
Sponsor: Prostate Cancer Clinical Trials Consortium

Sex: Male

Age: 21+

Code: NCT03151629

Recruiting

A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

for
Relapsed/Refractory Systemic Light Chain Amyloidosis
Location: Detroit MI, Columbus OH, Buffalo NY, Nashville TN,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06292780

Phase 1, Phase 2, Recruiting

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

for
Urinary Bladder Neoplasms, Neoplasm Metastasis,
Location: Detroit MI, Columbus OH, Chicago IL, Indianapolis IN,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT05614739

Phase 1, Recruiting